Stock ALNHT NH THERAGUIX SAS
Add to a list
To use this feature you must be a member
Log inSign up

Company NH TherAguix SAS

Equities

ALNHT

FR0013105954

Market Closed - Euronext Paris
Other stock markets
 08:34:17 2021-10-21 pm EDT 		5-day change 1st Jan Change
0.01 EUR -.--% Intraday chart for NH TherAguix SAS -.--% -.--%
2021 NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials CI

Managers

Managers TitleAgeSince
Vincent Carrère CEO
 Chief Executive Officer - -
Géraldine Le Duc FOU
 Founder - 15-12-10
Caroline Cayre DFI
 Director of Finance/CFO - 19-07-31
Markus Loeffler CTO
 Chief Tech/Sci/R&D Officer - 19-12-31

Members of the board

Members of the board TitleAgeSince
Philippe Archinard BRD
 Director/Board Member 63 19-02-21
Marc Le Bozec BRD
 Director/Board Member - 19-02-21
Hervé Eloi Dominique Brailly CHM
 Chairman 62 19-02-21
Philippe Boucheron BRD
 Director/Board Member - 19-02-21
Célia Hart BRD
 Director/Board Member - 19-02-21
Thibaut Roulon BRD
 Director/Board Member - 19-02-21
Nitza Thomasson-Perret BRD
 Director/Board Member 51 19-02-21
Yannick Plétan BRD
 Director/Board Member - 19-02-21
Olivier Tillement FOU
 Founder - 15-12-10
Géraldine Le Duc FOU
 Founder - 15-12-10

Company contact information

NH TherAguix SAS

29, chemin du Vieux Ch?ne Tarmac

38240, Meylan

+33 4 76 04 14 56

http://www.nhtheraguix.com
address NH TherAguix SAS(ALNHT)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. ALNHT Stock
  4. Company NH TherAguix SAS
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW